STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations.
Mohammed OA, Abdel-Reheim MA, Alamri MMS, Alfaifi J, Adam MIE, Saleh LA, Farrag AA, Yahia AIO, Abdel-Ghany S, AlQahtani AAJ, Bahashwan E, Eltahir HB, Mohammed NA, El-Wakeel HS, Hazem SH, Saber S.
Mohammed OA, et al. Among authors: farrag aa.
Pharmaceuticals (Basel). 2023 Jul 28;16(8):1080. doi: 10.3390/ph16081080.
Pharmaceuticals (Basel). 2023.
PMID: 37630994
Free PMC article.